Vicarious Surgical to Present at the Credit Suisse 30th Annual Healthcare Conference

Rhea-AI Summary

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced management's participation in the Credit Suisse 30th Annual Healthcare Conference on November 11 at 3:30 p.m. ET. The company aims to enhance surgical procedures' efficiency and patient outcomes through its innovative robotics technology. A live webcast of the presentation will be available on the company’s website, with an archive accessible post-conference. Vicarious Surgical, founded in 2014, has developed a groundbreaking surgical system recognized by the FDA with Breakthrough Device Designation.

WALTHAM, Mass.--(BUSINESS WIRE)-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced that management will participate in the Credit Suisse 30^th Annual Healthcare Conference. Management is scheduled to present on Thursday, November 11^th at 3:30 p.m. Eastern Time and will participate in virtual investor meetings throughout the day.

A live webcast of the presentation will be accessible to the public on the Company's website at https://www.vicarioussurgical.com/. An archive of the webcast will be available for replay following the conference.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass. Learn more at www.vicarioussurgical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211028006179/en/

Investor Contact

Lynn Lewis or Marissa Bych

Gilmartin Group

ir@vicarioussurgical.com

Press and Media Inquiries:

Jill Gross

Matter Communications

media@vicarioussurgical.com

Source: Vicarious Surgical Inc.

FAQ

What is Vicarious Surgical's participation in the Credit Suisse 30th Annual Healthcare Conference?

Vicarious Surgical will present on November 11 at 3:30 p.m. ET and participate in virtual investor meetings.

How can I access the live webcast of Vicarious Surgical's presentation?

The live webcast can be accessed on Vicarious Surgical's website.

What is the significance of Vicarious Surgical receiving Breakthrough Device Designation?

It highlights the company's advanced technology aimed at improving surgical procedures and patient outcomes.

When was Vicarious Surgical founded?

Vicarious Surgical was founded in 2014.

What technology does Vicarious Surgical utilize for surgery?

The company uses proprietary human-like surgical robots combined with virtual reality for minimally invasive surgery.